Latest Production News

Prominence Energy has extended its agreement to acquire the Gawler Hydrogen Project, allowing more time to secure final regulatory approvals and advance exploration in South Australia.

Radiopharm Theranostics has announced a $40 million equity raise via a two-tranche placement and a Share Purchase Plan (SPP) to fund its clinical programs and working capital. The offer includes new shares at $0.03 each with free attaching options, subject to shareholder approval.

Atlantic Lithium has revealed significant lithium-in-soil anomalies across its Rubino and Agboville licences in Côte d’Ivoire, alongside new spodumene pegmatite discoveries, signaling promising exploration potential in a largely underexplored region.

United States Antimony Corporation has made a non-binding indicative offer to acquire Larvotto Resources at a significant premium, proposing a strategic merger focused on antimony supply chain security and growth.

Avira Resources has secured a binding agreement to acquire the high-grade Mt Cattlin Gold Project in Western Australia, backed by a $2.5 million capital raise to advance exploration and resource development.

Flynn Gold Limited has reported significant progress in its Tasmanian gold exploration projects, including new high-grade gold discoveries and a successful $5 million capital raise to fund further drilling and development.

Audio Pixels Holdings has extended the maturity of $12.3 million in convertible notes to January 2027 and capitalised $4.05 million in accrued interest, enhancing its financial flexibility.

EV Resources has secured a 150-tonne-per-day processing plant near its Los Lirios project, fast-tracking antimony production and positioning itself as a key North American supplier.

Jindalee Lithium has launched an options offer linked to its recent Share Purchase Plan and placements, aiming to incentivize shareholders and raise capital for its lithium development projects. The options carry an exercise price of $0.825 and expire in late 2028.

Aurora Energy Metals reports strong metallurgical results and progress toward Eagle Energy Metals’ Nasdaq listing, advancing the Aurora Uranium Project’s development.

Mesoblast Limited reports a 69% jump in net revenues from its pioneering cell therapy Ryoncil in Q1 FY2026, propelled by expanded physician adoption and new reimbursement pathways. The company also secures convertible note funding and plans pivotal adult trials.

PolyNovo Limited reported a robust 33.3% increase in Q1 FY26 sales, driven by strong U.S. growth and a remarkable surge in NovoSorb MTX sales. The company also completed key infrastructure projects, positioning itself for further expansion.